Medtronic, Inc. (MDT) PT Lowered to $98 at Citi

Go back to Medtronic, Inc. (MDT) PT Lowered to $98 at Citi

Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; announces dividend increase

May 21, 2025 6:45 AM EDT

Building momentum in key franchises including Pulsed Field Ablation, TAVR, Cardiac Rhythm Management, Diabetes, Spine, and Neuromodulation

GALWAY, Ireland, May 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its fourth quarter (Q4) and fiscal year 2025 (FY25), which ended April 25, 2025.

... More

Medtronic announces intent to separate Diabetes business

May 21, 2025 6:44 AM EDT

Enables intense focus on highest margin growth drivers where Medtronic has leading core competencies

Leading, scaled, direct-to-consumer Diabetes business poised to become standalone company; only company with a complete ecosystem to address intensive insulin management

GALWAY, Ireland, May 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology,... More